NCT04038827View on ClinicalTrials.gov

Origin of CEC in Patients After Allo-HSCT

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

August 27, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

April 30, 2020

Conditions
Graft Versus Host Disease, AcuteEndothelial DysfunctionImmune Tolerance
Interventions
DIAGNOSTIC_TEST

D-CEC counting

By means of preliminary bulk separation step with the CellSearch system, single CEC will be sorted

Trial Locations (1)

25123

ASST Spedali Civili di Brescia, Brescia

All Listed Sponsors
collaborator

Università degli Studi di Brescia

OTHER

collaborator

University of Turin, Italy

OTHER

lead

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

OTHER

NCT04038827 - Origin of CEC in Patients After Allo-HSCT | Biotech Hunter | Biotech Hunter